DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography to Assess Heart Function

• Status: Completed
• Trial end date: 2008-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this clinical research study is to demonstrate the ability of Definity® enhanced versus unenhanced cardiac ultrasound to improve the accuracy and reproducibility of left ventricular ejection fraction (EF) when compared to magnetic resonance imaging (MRI).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Lantheus Medical Imaging

Criteria

Inclusion Criteria:

• Adult subjects 18 years of age or older

• Have a documented EF value ranging from 25% to 40%

• Have been scheduled to undergo or have undergone a cardiac MRI study

Exclusion Criteria:

• Severe valvular dysfunction

• Inability to remain supine for 30 minutes